Nasonex 24HR Allergy Disease Interactions
There are 4 disease interactions with Nasonex 24HR Allergy (mometasone nasal).
Mometasone nasal (applies to Nasonex 24HR Allergy) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Mometasone nasal should be used with caution in patients with impaired liver function. Concentrations of mometasone appear to increase with severity of liver dysfunction.
References
- (2022) "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc
- (2022) "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation, SUPPL-56
Mometasone nasal (applies to Nasonex 24HR Allergy) hyperadrenocorticism
Moderate Potential Hazard, Moderate plausibility.
Hypercorticism and adrenal suppression may occur when nasal corticosteroids, including mometasone nasal, are used in patients at risk for such effects. It is important that the recommended dosage of mometasone nasal is not exceeded.
References
- (2022) "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc
- (2022) "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation, SUPPL-56
Mometasone nasal (applies to Nasonex 24HR Allergy) infections
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral, Tuberculosis -- Latent
Patients who are using drugs that suppress the immune system, such as corticosteroids (including mometasone nasal), are more susceptible to infections than healthy subjects. Mometasone nasal should be used with caution, if at all, in patients with active or quiescent tuberculosis infection of the respiratory tract, untreated local or systemic fungal or bacterial infections, systemic viral or parasitic infections, or ocular herpes simplex due to the potential for worsening of these infections.
References
- (2022) "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc
- (2022) "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation, SUPPL-56
Mometasone nasal (applies to Nasonex 24HR Allergy) ocular toxicities
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Cataracts, Glaucoma/Intraocular Hypertension
Nasal and inhaled corticosteroids, including mometasone nasal, can result in the development of glaucoma and/or cataracts. Close monitoring is warranted in patients with a change in vision or history of increased intraocular pressure, glaucoma, and/or cataracts. Referral to an ophthalmologist should be considered for patients who develop ocular symptoms or use mometasone nasal long term.
References
- (2022) "Product Information. Ryaltris (mometasone-olopatadine nasal)." Hikma Americas, Inc
- (2022) "Product Information. Nasonex (mometasone nasal)." Schering-Plough Corporation, SUPPL-56
Nasonex 24HR Allergy drug interactions
There are 33 drug interactions with Nasonex 24HR Allergy (mometasone nasal).
More about Nasonex 24HR Allergy (mometasone nasal)
- Nasonex 24HR Allergy consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: nasal steroids
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.